Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02643914 : Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings
AgesMin: 21 Years Max: 65 Years
Inclusion Criteria:

21-65years of age

Moderate to severe addiction to smoking/nicotine (smoke at least 5 cigarettes a day,
confirmed by a score 6 on the Fagerstrom Test for Nicotine Dependence)

Willingness to withdraw from nicotine for 12 hours prior to testing

Eyesight correctable to 20/20 with contact lenses.

Exclusion Criteria:

Electrical implants such as cardiac pacemakers or perfusion pumps

Ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial
hearts, valves with steel parts, metal fragments, shrapnel, facial tattoos, or steel


Pregnancy or breastfeeding (for females, pregnancy status will be confirmed with urine

Chronic nasal congestion, sinusitis, or common cold Use of nicotine cessation therapy
(patch, gum, inhaler, nasal spray)

History of asthma, cardiovascular or peripheral vascular disease (anginas, arrhythmias,
myocardial infarction, Raynaud's disease, insulin dependent diabetes)

History of neurological disease (brain tumor, stroke, traumatic brain injury, epilepsy)

Current use of psychotropic medication
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557